Journal article
Antibiotic Augmentation of Thermal Eradication of Staphylococcus epidermidis Biofilm Infections
Pathogens (Basel), Vol.13(4), 327
04/16/2024
DOI: 10.3390/pathogens13040327
PMCID: PMC11054983
PMID: 38668282
Abstract
is a major contributor to bacterial infections on medical implants, currently treated by surgical removal of the device and the surrounding infected tissue at considerable morbidity and expense. In situ hyperthermia is being investigated as a non-invasive means of mitigating these bacterial biofilm infections, but minimizing damage to the surrounding tissue requires augmenting the thermal shock with other approaches such as antibiotics and discerning the minimum shock required to eliminate the biofilm.
biofilms were systematically shocked at a variety of temperatures (50-80 °C) and durations (1-10 min) to characterize their thermal susceptibility and compare it to other common nosocomial pathogens such as
and
. Biofilms were also exposed to three classes of antibiotics (ciprofloxacin, tobramycin and erythromycin) separately at concentrations ranging from 0 to 128 μg mL
to evaluate their impact on the efficacy of thermal shock and the subsequent potential regrowth of the biofilm.
biofilms were shown to be more thermally susceptible to hyperthermia than other common bacterial pathogens. All three antibiotics substantially decreased the duration and/or temperature needed to eliminate the biofilms, though this augmentation did not meet the criteria of synergism immediately following thermal shock. Subsequent reincubation, however, revealed strong synergism on a longer timescale.
Details
- Title: Subtitle
- Antibiotic Augmentation of Thermal Eradication of Staphylococcus epidermidis Biofilm Infections
- Creators
- Haydar A S Aljaafari - Department of Chemical Engineering, University of Technology, Baghdad 10066, IraqNadia I Abdulwahhab - Department of Applied Sciences, University of Technology, Baghdad 10066, IraqEric Nuxoll - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Pathogens (Basel), Vol.13(4), 327
- DOI
- 10.3390/pathogens13040327
- PMID
- 38668282
- PMCID
- PMC11054983
- NLM abbreviation
- Pathogens
- ISSN
- 2076-0817
- eISSN
- 2076-0817
- Grant note
- 18IPA34170108 / American Heart Association CBET-1133297 / National Science Foundation
- Language
- English
- Date published
- 04/16/2024
- Academic Unit
- Chemical and Biochemical Engineering
- Record Identifier
- 9984618624002771
Metrics
13 Record Views